Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- Check4 days agoChange DetectedThe previously unavailable study page now loads the full study record for NCT03666325, including the Study Details and related sections. It also adds glossary terms and metadata to support indexing and navigation.SummaryDifference69%

- Check11 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a minor administrative update rather than substantive changes to study details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new revision of the Study Details page. This is a metadata/version change and does not alter the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision was updated from v3.6.2 to v3.6.3. This reflects a small backend/template update rather than changes to the study information.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, indicating a software update; no study details or user actions are affected.SummaryDifference0.0%

- Check68 days agoChange DetectedNew navigation/help labels were added to the Study Details page, including 'Last verified', 'Last known status was', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with the revision tag 'Revision: v3.6.0'. The 'Intervention/Treatment' header replaces the previous 'Intervention / Treatment' formatting, and the old 'Revision: v3.5.5' tag was removed.SummaryDifference1%

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.